Associations between polypharmacy and physical performance measures in older adults
Tarih
2021Yazar
Kılıç, Cihan
Karan, Mehmet Akif
Bahat-Öztürk, Gülistan
Özkök, Serdar
Özer Aydın, Çağlar
Erbaş Saçar, Duygu
Çatıkkaş Demir, Nezahat Müge
Öbekli Erdoğan, Tuğba
Üst veri
Tüm öğe kaydını gösterÖzet
Objectives:A preserved ambulation is one of the keypoints for functionality and polypharmacy, a common problem in older adults, is associated with worse functional status. Our aim was to examine the associations of polypharmacy with certain physical performance measures used to evaluate ambulation.Methods:This retrospective, cross-sectional study was conducted in a geriatric outpatient clinic. Using ≥5 medications was accepted as polypharmacy. Usual gait speed (UGS), chair sit-to-stand test (CSST), timed up and go test (TUG) and short physical performance battery (SPPB) were performed to assess physical performance status. We created two models for logistic regression analyses: Model 1 was adjusted for age, sex and body mass index (BMI). We added comorbidities to Model 1 and further created Model 2.Results:There were 392 participants (69.1% were female, mean age: 73.9±6.2 years). Polypharmacy was seen in 62.5%. Participants with polypharmacy presented with a poor physical performance compared to the no-polypharmacy group (p<0.001, for each). In multivariate analyses, polypharmacy was independently associated with poor SPPB (Odds Ratio (OR)=2.5; 95% Confidence Interval (CI)=1.3-4.7andOR=2.4; 95% CI=1.2-4.8forModel 1 and 2,respectively) and long CSST (OR= 2.6; 95% CI=1.3-5.2andOR=3.7; 95% CI=1.7-8.2forModel 1 and 2, respectively). There was a significant association between polypharmacy and slow UGSin Model 1(OR=1.9; 95% CI=1.0-3.5); but relationship did not persist after adding comorbidities into the first model (OR=1.6; 95% CI= 0.8-3.1). There was no significant association between long TUG and polypharmacy in any of the models.Conclusion:Polypharmacy is well-known with its association with falls and fractures in older adults and this might be explained by its association with poor physical performance. Whether polypharmacy causes a deterioration in physical performance is an issue needs to be enlightened by further longitudinal studies.
Bağlantı
http://hdl.handle.net/20.500.12627/175698https://doi.org/10.1016/j.archger.2021.104553
https://authors.elsevier.com/c/1dv7F_3pl7yrLv
Koleksiyonlar
- Makale [92796]
